I recently bought shares of seven different companies. One of those companies was AbbVie (NYSE: ABBV). I had different reasons for buying each of the stocks. Some were in sectors in which I didn’t already have much exposure in my portfolio. That wasn’t the case with AbbVie, though. I already owned quite a few healthcare stocks and exchange-traded funds (ETFs).